Pharma's bad karma: Resistance is not futile

Journal of General Internal Medicine

Volumn 18, Issue 4, 2003, Pages 315-316

  Carrasquillo, Olveen ^a   Goodman, Robert L ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; PHENAZOPYRIDINE;

ADVERTIZING; DRUG INDUSTRY; DRUG MARKETING; DRUG MISUSE; DRUG USE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; PHARMACY; PRACTICE GUIDELINE; URINARY TRACT INFECTION;

EID: 0037961509     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.2003.30290.x     Document Type: Editorial

References (12)

1. Prescription Drugs and Mass Media Advertising. 2000. Washington DC: National Institute for Health Care Management Research and Educational Foundation; 2001.
2. For an exhaustive bibliography of pharmaceutical promotion see URL http://www.healthyskepticism.org. Accessed February 5, 2003.
3. Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS. The quantity and quality of scientific graphs in pharmaceutical advertisements. J Gen Intern Med. 2003:18:294-7.
4. Tufte ER. Visual Display of Quantitative Information. Cheshire. Conn: Graphic Press: 1983.
5. Shi C-W, Asch SM, Fielder E, et al. Usage patterns of over-the-counter phenazopyridine (pyridium). J Gen Intern Med. 2003;18:281-7.
6. Uristat can help. Available at: URL http://www.uristat.com/ shorthed.htm. Accessed February 4. 2003.
7. Wolfe SM. Remedies needed to address the pathology in reporting adverse reactions and Food and Drug Administration use of reports. J Gen Intern Med. 2003;18:72-3.
8. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Available at URL http://www.icmje.org/index.html#advertising. Accessed February 3, 2003.
9. Society of General Internal Medicine. Policy on acceptance and disclosure of external funds. Available at: URL: http://www.sgim. org/policies.cfm. Accessed February 3, 2003.
10. Angell M. Is academic medicine for sale? N Engl J Med. 2000;342:1516-8.
11. Goodman RL, Landefeld S, Steinman M. A curriculum on physician-pharmaceutical interactions. Available at: http://www.nofreelunch.org/nofreelunchweb4/index.htm. Accessed February 3, 2003.
12. Fletcher RH. Adverts in medical journals: caveat lector. Lancet. 2003;361:10-1.